INTERGARD™ Knitted

The Optimal Choice for Abdominal Vascular Reconstruction

MAQUET's collagen-coated INTERGARD Knitted vascular grafts are designed with a unique reverse locknit construction that offers excellent handling and suturing characteristics. It also results in long-term stability and resistance to dilatation. INTERGARD Knitted grafts have a burst strength nearly twice that of other knitted polyester collagen- impregnated grafts on the market,1 which significantly reduces the potential for postoperative dilatation.2 

To promote optimal healing and long-term patency, INTERGARD Knitted grafts have a low-profile velour on the external surface. They incorporate a soft, open crimp design to minimize turbulence and enhance neointima formation.

Summary of benefits:

• Demonstrated long-term durability and resistance to postoperative dilation.2
• Proprietary knit design produces outstanding handling and suturability.
• Low-profile velour construction designed to promote optimal healing.
• Proven clinical safety and efficacy: clinical trial results demonstrated fewer complications and a higher primary patency rate compared with another commercially available collagen-impregnated graft.3

INTERGARD Knitted grafts are available in Straight, Trifurcated, Quadrifurcated, UltraThin, and Small Caliber configurations, as well as in radially supported versions.

INTERGARD Knitted Small Caliber Grafts 

• Proven alternative for peripheral bypass procedures when vein is not available.3
• Designed to overcome complications such as hyperplasia, host vessel mismatch, and suture hole bleeding.
• Available radially supported with an external polypropylene support for all peripheral applications, including axillofemoral, axillobifemoral and fem-fem crossover procedures.

1. Data on file.

2. Swartbol P, Albrechtsson U, Parsson H, Norgren L. Dilatation of aortobifemoral grafts after a mean implantation of 5 years. International Angiology. 1996;15(3):236-239.

3. INTERGARD Collagen Coated Knitted Vascular Grafts: Results of the U.S. Clinical Trial.